Trading at $1.41, Akebia Therapeutics, Inc. (AKBA) is publicly traded in the U.S. valued at $377.71M. MoonshotScore rates it 61/100 — Hold. AI signals are mixed — do more research.

For informational purposes only. Not financial advice.